屈大麻酚药品研究国内外文献综述  

Literature review of the drug δ-9-THC

作　　者：张昱 ZHANG Yu(Jiangsu Nhwa Pharmaceutical Co.,Ltd,Xuzhou Jiangsu 221000)

机构地区：[1]江苏恩华药业股份有限公司,江苏徐州221000

出　　处：《中南药学》2018年第10期1404-1411,共8页Central South Pharmacy

摘　　要：屈大麻酚是作用于中枢神经系统(CNS)及孤立束核(NTS)的止吐药,其作用受体不同于市售其他止吐药,可为止吐提供新的治疗位点,在使用了其他常规止吐药治疗无明显疗效的时候,屈大麻酚可有效改善患者治疗和生存的状况。δ-9-THC is a drug for the central nervous system and an anti-nausea drug for isolated nucleus. The role of receptor is different from that of other anti-nausea drugs on the markert, so δ-9-THC provides a new treatment site. When other routine anti-nausea drug treatments have no obvious curative effect, δ-9-THC may effectively improve the condition of the patient and chance of survival.

关 键 词：屈大麻酚 机制 

分 类 号：R338[医药卫生—人体生理学]